US
Umesh Sharadrao Shaligram
About Umesh Sharadrao Shaligram
Data last updated:
Umesh Sharadrao Shaligram is a Whole-Time Director at Serum Institute Of India Private Limited (since 2021), Director at Serum Institute Life Sciences Private Limited (since 2020) and Designated Partner at Sri Thakur Biotech Llp (since 2021). The companies operate in Pharma, Life Sciences and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹11,015 Cr; the largest is Serum Institute Of India Private Limited at ₹10,854 Cr (FY 2025). Earlier, Umesh Sharadrao Shaligram was a Director at Amron Realtors Private Limited (2005–2015) and Designated Partner at Vivaswan Farms Llp (2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Serum Institute Of India Private Limited U80903PN1984PTC032945 | Whole-Time Director | 24 Aug 2021 | 1984 | ₹10,854 Cr (FY 2025) | Active |
 Serum Institute Life Sciences Private Limited U24290PN2020PTC191301 | Director | 30 Jun 2020 | 2020 | ₹161 Cr (FY 2025) | Active |
| Sri Thakur Biotech Llp ABA-0236 | Designated Partner | 27 Dec 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Amron Realtors Private Limited U70102PN2005PTC021143 | Director | 17 Aug 2005 | 2005 | ₹4.73 Cr (FY 2025) | Active |
| Vivaswan Farms Llp AAY-0351 | Designated Partner | 03 Aug 2021 | 2021 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Umesh Sharadrao Shaligram
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Umesh Sharadrao Shaligram
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Umesh Sharadrao Shaligram
Umesh Sharadrao Shaligram currently holds 3 directorships: Serum Institute Of India Private Limited (Whole-Time Director, since 24 Aug 2021, revenue ₹10,854 Cr (FY 2025)); Serum Institute Life Sciences Private Limited (Director, since 30 Jun 2020, revenue ₹161 Cr (FY 2025)); Sri Thakur Biotech Llp (Designated Partner, since 27 Dec 2021).
Umesh Sharadrao Shaligram was first appointed on 17 Aug 2005 as Director at Amron Realtors Private Limited. The most recent appointment on record is 27 Dec 2021 at Sri Thakur Biotech Llp.
The 2 current companies of Umesh Sharadrao Shaligram that report revenue have a combined latest revenue of ₹11,015 Cr: Serum Institute Of India Private Limited ₹10,854 Cr (FY 2025); Serum Institute Life Sciences Private Limited ₹161 Cr (FY 2025).
Umesh Sharadrao Shaligram held 2 earlier board appointments: Amron Realtors Private Limited (Director, 17 Aug 2005 to 01 Jun 2015); Vivaswan Farms Llp (Designated Partner, 03 Aug 2021 to 18 Oct 2021).
The current boards of Umesh Sharadrao Shaligram's companies include Adar Cyrus Poonawalla (Serum Institute Of India Private Limited), Adar Cyrus Poonawalla (Serum Institute Of India Private Limited), Behroze Zavareh Poonawalla (Serum Institute Of India Private Limited), Cyrus Soli Poonawalla (Serum Institute Of India Private Limited), Kedar Shashikant Gokhale (Serum Institute Of India Private Limited), Natasha Adar Poonawalla (Serum Institute Of India Private Limited), among others.